Makita S - Search Results

1

Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma.

Goto H, Makita S, Kato K, Tokushige K, Fujita T, Akashi K, Izutsu K, Teshima T. Goto H, et al. Among authors: makita s. Int J Clin Oncol. 2020 Sep;25(9):1736-1743. doi: 10.1007/s10147-020-01699-6. Epub 2020 May 24. Int J Clin Oncol. 2020. PMID: 32448949 Free PMC article. Clinical Trial.

2

Clinicopathological features of classical Hodgkin lymphoma in patients ≥ 40 years old, with special reference to composite cases.

Maeshima AM, Taniguchi H, Nomoto J, Makita S, Kitahara H, Fukuhara S, Munakata W, Suzuki T, Maruyama D, Kobayashi Y, Tobinai K. Maeshima AM, et al. Among authors: makita s. Jpn J Clin Oncol. 2015 Oct;45(10):921-8. doi: 10.1093/jjco/hyv101. Epub 2015 Jul 22. Jpn J Clin Oncol. 2015. PMID: 26206898

3

Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphoma.

Makita S, Maruyama D, Maeshima AM, Taniguchi H, Miyamoto K, Kitahara H, Fukuhara S, Munakata W, Kobayashi Y, Itami J, Tobinai K. Makita S, et al. Int J Hematol. 2016 Aug;104(2):236-44. doi: 10.1007/s12185-016-2007-1. Epub 2016 Apr 16. Int J Hematol. 2016. PMID: 27086350

4

Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma.

Makita S, Maeshima AM, Taniguchi H, Kitahara H, Fukuhara S, Munakata W, Suzuki T, Maruyama D, Kobayashi Y, Tobinai K. Makita S, et al. Int J Hematol. 2016 Sep;104(3):396-9. doi: 10.1007/s12185-016-2018-y. Epub 2016 May 12. Int J Hematol. 2016. PMID: 27169615

5

Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.

Maeshima AM, Taniguchi H, Toyoda K, Yamauchi N, Makita S, Fukuhara S, Munakata W, Maruyama D, Kobayashi Y, Tobinai K. Maeshima AM, et al. Among authors: makita s. Br J Haematol. 2016 Sep;174(6):923-31. doi: 10.1111/bjh.14153. Epub 2016 Jul 27. Br J Haematol. 2016. PMID: 27460179 Free article.

6

Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.

Makita S, Tobinai K. Makita S, et al. Hematol Oncol Clin North Am. 2017 Apr;31(2):239-253. doi: 10.1016/j.hoc.2016.11.007. Epub 2017 Jan 30. Hematol Oncol Clin North Am. 2017. PMID: 28340876 Review.

7

Disease-oriented treatment of T-cell lymphoma.

Makita S, Tobinai K. Makita S, et al. Hematol Oncol. 2017 Jun;35 Suppl 1:54-59. doi: 10.1002/hon.2401. Hematol Oncol. 2017. PMID: 28591416 Review. No abstract available.

8

Mogamulizumab for the treatment of T-cell lymphoma.

Makita S, Tobinai K. Makita S, et al. Expert Opin Biol Ther. 2017 Sep;17(9):1145-1153. doi: 10.1080/14712598.2017.1347634. Epub 2017 Jul 3. Expert Opin Biol Ther. 2017. PMID: 28649848 Review.

9

Atypical radiological presentation of pulmonary invasion of diffuse large B-cell lymphoma mimicking Pneumocystis jiroveci pneumonia.

Higashiyama RI, Makita S, Maeshima AM, Maruyama D. Higashiyama RI, et al. Among authors: makita s. Jpn J Clin Oncol. 2018 Mar 1;48(3):298-299. doi: 10.1093/jjco/hyx194. Jpn J Clin Oncol. 2018. PMID: 29351631 No abstract available.

10

Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab.

Ito Y, Makita S, Maeshima AM, Hatta S, Suzuki T, Yuda S, Fukuhara S, Munakata W, Suzuki T, Maruyama D, Izutsu K. Ito Y, et al. Among authors: makita s. Intern Med. 2018 Aug 15;57(16):2395-2398. doi: 10.2169/internalmedicine.0578-17. Epub 2018 Mar 9. Intern Med. 2018. PMID: 29526963 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

543 results

Search Page